China Telecom's Asia Direct Cable (ADC) Capacity Enters Service Ahead of Schedule, Bolstering Regional Economic Development
HONG KONG, Feb. 14, 2025 /PRNewswire/ -- On February 14, 2025, China Telecom officially announced that the capacity of the Asia Direct Cable (ADC), an international submarine cable initiative led by China Telecom, has been officially in service...
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers
HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug...
KONE to equip a five-star hotel and commercial complex in Sihanoukville, Cambodia
SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- KONE Corporation, a global leader in the elevator and escalator industry, has won an order to provide a suite of People Flow® solutions for the Peninsula Integrated Resort by Chinese foreign investment firm,...
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), today announced that BeiGene. Ltd. has exercised its exclusive option to acquire global...
Asia Direct Cable (ADC) International Submarine Cable Officially Launched: Bridging Asia and Supporting Regional Digital Transformation
HONG KONG, Dec. 20, 2024 /PRNewswire/ -- On 8th November 2024, the Asia Direct Cable (ADC) international submarine cable, initiated and led by China Telecom, officially announced its commencement of operations. As a leading communication...
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS
PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and...
Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement
Adcendo ApS exercises its option to utilize Duality Biologics' platform to further enhance its first-in-class ADC pipeline PRINCETON, N.J., SHANGHAI and SUZHOU, China, Nov. 26, 2024 /PRNewswire/ -- Duality Biologics ("Duality"), a clinical-stage...